Skip to content

Haskap and Endurance Running Performance

The Influence of Haskap Berry on Exercise Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04837898
Enrollment
30
Registered
2021-04-08
Start date
2021-04-12
Completion date
2021-12-08
Last updated
2022-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Performance

Keywords

berry, running, time trial

Brief summary

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

Detailed description

Participants will consume haskap berry powder or an isocaloric placebo for 7 days. They will be required to run on a treadmill before and after supplementation to asses the influence on the intervention on aerobic performance parameters. Other performance parameters such as blood lactate, heart rate, ratings of perceived exertion and respiratory variables will also be monitored throughout the various elements of the exercise trials.

Interventions

DIETARY_SUPPLEMENTHaskapa

Haskapa Ltd, Oxford, UK

DIETARY_SUPPLEMENTPlacebo

isocaloric to the haskap powder

Sponsors

Mibelle Group Biochemistry
CollaboratorINDUSTRY
Haskapa Ltd
CollaboratorUNKNOWN
Northumbria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Supplement will be pre-weighed by an individual (independent of the study) and provided to participants in sealed packets

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy non-smoking males * completed a 5 km run (in less than 25 minutes) within the 6 weeks prior to the study

Exclusion criteria

* female * allergies to fruit or dairy, currently taking any nutritional supplements (e.g. vitamins, antioxidant, herbal or sports enhancing supplements) or medication that might affect the study outcome * history of gastrointestinal, renal or cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
5km time trialChange from baseline at 7 daystime to complete the trial (seconds)
V̇O2peak testChange from baseline at 7 daystime to exhaustion (seconds)

Secondary

MeasureTime frameDescription
Blood lactate response during submaximal tests, maximal and time trialChange from baseline at 7 dayslactate (mmol/L)
rating of perceived exertion during submaximal tests, maximal and time trialChange from baseline at 7 daysRPE (/20)
heart rate during submaximal tests, maximal and time trialChange from baseline at 7 days(BPM)
VO2 during submaximal tests, maximal testsChange from baseline at 7 days(oxygen uptake - relative ml/kg/min and absolute l/min)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026